DASHENLIN PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss

The total revenue of 603233 for the last quarter is 5.71 B CNY, and it's 5.18% lower compared to the previous quarter. The net income of Q3 23 is 256.93 M CNY.